
NICVD Karachi Tender Notice Nos. 04/2026, 04A/2026, 04B/2026, 04C/2026 & 04D/2026 (EPAD/SPPRA)
NICVD Karachi Tender Notice Nos. 04/2026, 04A/2026, 04B/2026, 04C/2026 & 04D/2026 (EPAD/SPPRA) · Karachi · Jang,
Tender advertisement published in Jang on Sunday, 16 August 2026, listed under Karachi, Pakistan. Issued by NICVD Karachi Tender Notice Nos. 04/2026, 04A/2026, 04B/2026, 04C/2026 & 04D/2026 (EPAD/SPPRA). The last date printed on the advertisement was Friday, 11 September 2026 and has passed.
The original image is temporarily unavailable. Use the source link or the details below. Open the full-size clipping Advertisement details
National Institute of Cardiovascular Diseases (NICVD), Karachi invites sealed tenders under EPAD/SPPRA rules for the following tender packages. Tender documents, eligibility requirements and detailed scope are available from NICVD/EPAD (SPPRA) as indicated. Interested bidders should submit bids by the specified closing dates; bids will be opened as per the schedule.
| Tender No. | Brief / Reference | Bid closing date |
|---|---|---|
| 04/2026 | Refer to NICVD tender documents (EPAD/SPPRA) | 2026-09-02 |
| 04A/2026 | Refer to NICVD tender documents (EPAD/SPPRA) | 2026-09-04 |
| 04B/2026 | Refer to NICVD tender documents (EPAD/SPPRA) | 2026-09-07 |
| 04C/2026 | Refer to NICVD tender documents (EPAD/SPPRA) | 2026-09-09 |
| 04D/2026 | Refer to NICVD tender documents (EPAD/SPPRA) | 2026-09-11 |
Important notes: Non-refundable tender document fee: Rs.2,000/-. Bid security as specified in the tender documents (2% is indicated). Tender documents and full terms are available from NICVD/EPAD (SPPRA) and NICVD website. NICVD reserves the right to accept or reject any/all bids as per rules.
Issuer contact and website: National Institute of Cardiovascular Diseases (NICVD), Karachi. Website: www.nicvd.org. (Refer to official NICVD tender advertisement for full details and submission procedure.)
Published in Jang on Sunday, 16 August 2026. DailyAds.pk indexes newspaper advertisements; the original notice and the issuing organisation remain the source for final terms and eligibility.










